HTB

COVID-19: HIV and COVID-19 coinfection

BHIVA advice on access to COVID-19 vaccines and shielding in the UK

HIV positive people in the UK now elligible for COVID vaccinations – and to become available at HIV clinics

BHIVA and EACS update HIV as a higher risk for COVID-19: supports priority vaccine (January 2021)

Recent studies on HIV and COVID-19 coinfection

Very low-level HIV viraemia might continue after COVID-19

Recent studies on HIV and COVID-19 coinfection

BHIVA statement on HIV positive people and access to COVID vaccines

COVID-19 antibody testing for HIV positive people in the UK: HIV organisations reverse previous exclusion

HIV positive people at higher risk of worse outcomes from COVID-19 in UK study

US study of HIV positive people with COVID-19 reports worse outcomes with comorbidities and having a CD4 <200

Outcomes from COVID-19 in French cohort of 54 HIV positive people on ART

Oxford COVID vaccine enrolling HIV positive people at two London sites

COVID-19 outcomes in HIV positive people in two large US cohorts

HIV associated with worse outcomes from COVID-19 in UK ISARIC and OpenSAFELY databases

European and UK doctors review latest studies on HIV and COVID-19 coinfection

Pneumocystis Jirovecii Pneumonia (PJP) mistaken for COVID-19 in late stage undiagnosed: urgency of including HIV testing on admission

NYC cohort reports similar outcomes from COVID-19 in HIV positive vs HIV negative adults

Spanish study reports associations between COVID-19 and HIV treatment including NRTIs

Review of COVID-19 in people with immune suppression

Latest studies on HIV/COVID-19 coinfection

HIV positive people in South Africa at increased risk of dying from COVID-19: first data from country with high prevalence of HIV and TB

Update on Western Cape data: people with HIV have small increased risks from COVID-19

HIV and COVID-19 coinfection: case reports, retrospective cohorts and outcomes

Higher rates of serious outcomes in HIV and COVID-19 coinfection in Germany: cautious review

HIV is not linked to higher risk of COVID-19 in large New York cohort

Case-studies show darunavir does not protect against CoV-2

Why it is important to include HIV status and HIV testing in managing COVID-19

COVID-19 symptoms in HIV positive people similar to general population in Wuhan 

Case study of COVID-19 in HIV positive person with history of HCV

Case series of five HIV positive people diagnosed with COVID-19 in Spain